A DOUBLE BLIND, RANDOMIZED, VEHICLE-CONTROLLED, PARALLEL-GROUP EVALUATION OF CIVAMIDE (ZUCAPSAICIN) 0.01% AND VEHICLE NASAL SPRAYS IN THE TREATMENT OF POSTHERPETIC NEURALGIA OF THE TRIGEMINAL NERVE
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Zucapsaicin (Primary)
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Winston Laboratories
- 11 Feb 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 25 Sep 2014 Planned End Date changed from 1 Oct 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 25 Sep 2014 Planned primary completion date changed from 1 Aug 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.